EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
Recent Searches
Sebastian Braun
EY World Entrepreneur Of The Year™ 2025 finalist, Germany
Chairman of the Supervisory Board of CHEPLAPHARM SE
Sebastian Braun is ensuring the availability of essential medicines worldwide.
Sebastian Braun has been a driving force in the pharmaceutical industry since he took the helm of CHEPLAPHARM SE in 2003. With a vision to preserve the global diversity of medicines, Sebastian has transformed the company from a midsized German firm into a formidable international corporate group. Under his leadership, CHEPLAPHARM has seen remarkable revenue growth over the past two decades.
The company specializes in acquiring off-patent branded medicines from major pharmaceutical companies and integrate them into its operations to make them available in 145 countries. With a robust network of 125 contract manufacturers and 100 distribution partners, CHEPLAPHARM guarantees a steady supply of reliable, trusted medications that would otherwise disappear from the market. Approximately 39% of the company’s lineup are niche products with limited alternatives, and about 30% are listed on the World Health Organization’s Model List of Essential Medicines.
Sebastian’s approach creates a win-win scenario: pharmaceutical companies can focus on research and development, patients gain access to essential medicines, and CHEPLAPHARM thrives, providing jobs to around 800 employees. His commitment to enhancing health care access and sustainability illustrates his global impact and inspires the future of the pharmaceutical sector.
Success is no coincidence — it is always a combination of preparation and opportunity. Be ready to act boldly when the opportunities arise.